NeuroSense Therapeutics Ltd. Retained Earnings
NeuroSense Therapeutics Ltd. (NRSN) had Retained Earnings of -$47.78 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-03-31
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$47.78M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$41.37M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$36.66M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$32.38M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$47.78M 20-F · filed 2026-03-31 |
| 2025-06-30 | -$41.37M 6-K · filed 2025-08-01 |
| 2024-12-31 | -$36.66M 20-F · filed 2026-03-31 |
| 2024-06-30 | -$32.38M 6-K · filed 2024-09-30 |
| 2023-12-31 | -$26.12M 20-F · filed 2025-04-07 |
| 2022-12-31 | -$16.01M 6-K · filed 2024-06-17 |